Gloo Holdings, Inc., a technology platform serving the faith and flourishing ecosystem, today announced the pricing of its initial public offering of 9,100,000 shares of its Class A common stock at a public offering price of $8.00 per share. Gloo has also granted the underwriters a 30-day option to purchase up to an additional 1,365,000 […]
EDINBURGH, United Kingdom, Nov. 19, 2025 (GLOBE NEWSWIRE) — A pioneering biotech company using fungal technology to enhance tree growth and survival rates is set to expand into North America after raising $5.5 million (£4.5 million) in fresh investment. Rhizocore Technologies' flagship product, RhizoPellets(TM), helps trees survive planting and grow stronger and faster by pairing
Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, today announced it has been awarded with a landmark development contract by the Biomedical Advanced Research and Development Authority (BARDA), part of Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services (HHS), for
Biotech Firm Raises £4.5M for North American Expansion Rhizocore Technologies secures capital to fuel U.S. market entry and production capacity GlobeNewswire November 19, 2025 EDINBURGH, United Kingdom, Nov. 19, 2025 (GLOBE NEWSWIRE) — A pioneering biotech company using fungal technology to enhance tree growth and survival rates is set to expand into North America after
Calculus will offer Aprecomm's award-winning software solutions-including Wi-Fi optimization and support automation tools-to its expanding base of ISP customers in developing markets spanning the Middle East & Africa, India & Mexico. Calculus, a global leader in advanced network innovation, today announced a strategic partnership with Aprecomm, a leading provider of intuitive, self-healing network and customer
On November 18, 2025, Lianlian DigiTech announced the establishment of its Overseas Business Headquarters in Hong Kong, signaling the beginning of a new phase of deeper and more accelerated global growth. This is another major strategic initiative by Lianlian to build a new global digital payment ecosystem with Hong Kong as its hub, following its
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the pricing of an underwritten public offering of shares of Class A common stock at a price to the public of $101.00 per share. Nuvalent is selling 4,950,496 shares in the offering.
NEW YORK, NY / ACCESS Newswire / November 18, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=178057&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / November 18, 2025 / If you suffered a loss on your Molina Healthcare, Inc. (NYSE:MOH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/molina-healthcare-inc-lawsuit-submission-form?prid=178056&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
The global Wearable Medical Devices Market is entering a decisive decade, reshaping how patients, clinicians, and health systems interact with real-time healthcare data. According to recent research, the market was valued at $42.1 billion in 2024 and is projected to reach $184.75 billion by 2033, driven by rapid consumer adoption, healthcare digitalization, and the integration